CBC, short for cannabichromene, is one of the major cannabinoids found naturally in cannabis. It doesn’t get you high, but it’s drawing attention for its potential anti-inflammatory and pain-relieving properties. CBC is actually one of the most abundant cannabinoids in the plant, though it’s far less well-known than THC or CBD.
How CBC Forms in the Cannabis Plant
Every major cannabinoid in cannabis starts from the same parent molecule: cannabigerolic acid, or CBGA. As the plant matures, enzymes convert CBGA into different cannabinoid acids. One of those is CBCA (cannabichromenic acid), the direct precursor to CBC. When CBCA is exposed to heat at roughly 105°C (221°F), it loses a carbon dioxide molecule in a process called decarboxylation and becomes CBC. This is the same type of chemical conversion that turns THCA into THC and CBDA into CBD when you smoke, vape, or cook cannabis.
Because all these cannabinoids share a common origin, the ratio of CBC to THC to CBD in any given plant depends on which enzymes the plant produces, which is determined by genetics. Some cannabis strains naturally produce more CBCA, resulting in higher CBC levels in the final product.
How CBC Differs From CBD
CBC and CBD share the same molecular formula, meaning they’re built from the same atoms in the same quantities. The difference is in how those atoms are arranged, which changes how each compound interacts with receptors throughout your body.
CBD is sometimes described as a “multi-targeted” cannabinoid. It interacts indirectly with the body’s main cannabinoid receptors (CB1 and CB2) and also engages non-cannabinoid pathways, including serotonin signaling. CBC is more selective. It has a stronger affinity for CB2 receptors, which are concentrated in immune cells and tissues involved in inflammation. CBC doesn’t bind well to CB1 receptors (the ones THC activates to produce a high), which is why it has no intoxicating effect. Instead, it activates ion channels linked to pain perception, including several temperature-sensitive receptors in nerve cells.
In practical terms, CBD has a broader, more generalized profile, while CBC appears to work more narrowly on inflammation and pain pathways.
Pain and Inflammation Effects
Animal research published in the journal Biomedicines found that CBC reduced pain-related behaviors across a range of stimuli, including inflammatory pain, heat-induced pain, and nerve-related (neuropathic) pain. Molecular modeling in the same study identified that CBC can dock with several receptors involved in pain signaling, including one of the same targets that traditional anti-inflammatory drugs like ibuprofen act on.
CBC also activates CB2 receptors and multiple ion channels involved in how nerves detect temperature and irritation. This combination of receptor interactions may explain why it appears to address different types of pain rather than just one. None of this means CBC is a proven painkiller in humans yet, but the breadth of its receptor activity is what makes researchers interested.
Potential Effects on Brain Cells
A study published in the journal Neurochemistry International tested CBC alongside CBD and CBG on mouse neural stem cells and found that CBC stood out. It improved the survival rate of these stem cells during a critical development phase. The cells treated with CBC showed increased levels of a protein associated with stem cell maintenance while showing reduced levels of a marker linked to a specific type of brain support cell called astroglia.
Put more simply, CBC appeared to help neural stem cells stay viable longer and keep their potential to develop, rather than prematurely turning into support cells. The researchers traced this effect to changes in energy signaling within the cells, specifically higher levels of ATP (the molecule cells use for energy). This is early-stage, lab-dish research, not a proven benefit in living humans, but it suggests CBC may interact with the brain in ways that other cannabinoids do not.
Skin and Acne Research
CBC has also been studied for its effects on the oil-producing glands in skin. A 2016 study on human sebocytes (the cells that produce the oily substance called sebum) found that CBC inhibited baseline oil production. It also reduced the excessive oil production triggered by a fatty acid that mimics acne conditions in lab settings. CBC and several other cannabinoids tested in the same study showed anti-inflammatory properties relevant to inflammatory skin conditions.
At high concentrations, CBC was even able to induce cell death in sebocytes in the lab. Separately, topical application of CBC and related cannabinoids was shown to reduce inflammation in another study. These findings are preliminary, but they point to CBC as a cannabinoid with potential relevance for skin health beyond what THC or CBD alone might offer.
How to Find CBC in Cannabis Products
Most standard cannabis flower contains relatively low concentrations of CBC compared to THC or CBD, though the exact amount varies by strain. You’re more likely to encounter meaningful CBC levels in full-spectrum or broad-spectrum extracts, which preserve the plant’s full range of cannabinoids rather than isolating just one. Some companies now sell CBC-specific tinctures or oils, typically derived from hemp.
Because CBC is non-intoxicating and derived from the same plant material as legal hemp-derived CBD, it generally falls under the same regulatory framework. In the United States, cannabinoids derived from hemp containing less than 0.3% THC by dry weight are federally permitted under the 2018 Farm Bill, though state laws vary. If you’re shopping for CBC products, look for third-party lab results (certificates of analysis) that confirm the CBC content and verify that THC levels are within legal limits.
The Entourage Effect
One reason CBC matters even to people who aren’t seeking it out specifically is the entourage effect, the theory that cannabinoids work better together than in isolation. CBC’s distinct receptor profile, particularly its affinity for CB2 receptors and pain-related ion channels, means it may complement what THC and CBD are doing through different pathways. This is why full-spectrum products, which retain CBC alongside other minor cannabinoids and terpenes, are often considered more effective than single-cannabinoid isolates by both consumers and researchers studying whole-plant cannabis.